Oct 3, 2011
SANTA MONICA, Calif., Oct. 3, 2011 /PRNewswire/ -- Derycz Scientific, Inc. (OTC-BB: DYSC), a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, announced today that its subsidiary Reprints Desk, Inc.®, along with the Center for Business Intelligence (CBI), have opened online registration for a free webinar for life sciences procurement professionals at 10:00 am EDT on Tuesday, October 18. The webinar, featuring Reprints Desk's Global Sales Director and former AstraZeneca procurement professional Armand Brevig, will identify how fragmented purchasing of millions of dollars for journal article reprints occurs each year by marketing and sales departments within life science companies. It will also examine the benefits for procurement teams to target this hidden spend category by working with an article supply company. Procurement professionals can register online at http://www.cbinet.com/webinar/ec11584.
Mr. Brevig stated, "Spending on clinical reprints by Pharmaceutical and Medical Device companies can reach into the tens of millions of dollars each year. This marketing spend may increase dramatically with growing sales force adoption of new technologies such as the iPad and continued investment in apps and online portals for healthcare professionals (HCPs), across both mature and emerging markets."
Scholarly, peer-reviewed journal articles are important educational tools for healthcare professionals, helping them to understand new therapies and stay current on changing standards of care. HCPs access journal articles through subscriptions and libraries, discovery tools such as PubMed, alerting services, and through the sales, marketing, and medical affairs channels of Life Science companies. Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions and scientific, technical, and medical (STM) research.
About Reprints Desk®
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions and scientific, technical, and medical (STM) research. Organizations based on intellectual property (IP) choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Outsell Inc., an independent analyst and advisory firm, ranked Reprints Desk #1 in the most recent Document Delivery Vendor Scorecard. Reprints Desk is a wholly-owned subsidiary of Derycz Scientific, Inc.
About Derycz Scientific®
Derycz Scientific, Inc. develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk, Inc., Pools Press, Inc. and Techniques Appliquees aux Arts Graphiques, S.p.A. (TAAG). Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprints Desk is an innovator in content retrieval and ePrint delivery, with services designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for more than 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces and newsletters; and works with publishers who wish to outsource a portion of or all of their reprints business. TAAG offers printing, distribution and information logistics services, with core competencies in the professional production and distribution of clinical trial kits and clinical article reprints for the life sciences industry. For more information, please visit www.deryczscientific.com.
Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K. The Company assumes no obligation to update the cautionary information in this release.
SOURCE Derycz Scientific, Inc.